Pharmacogenetic testing: current evidence of clinical utility

Abstract excerpt

Over the last decade, the number of clinical pharmacogenetic tests has steadily increased as understanding of the role of genes in drug response has grown. However, uptake of these tests has been slow, due in large part to the lack of robust evidence demonstrating clinical utility. We review the evidence behind four pharmacogenetic tests and discuss the barriers and facilitators to uptake: 1) warfarin (drug...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory mediators and NSAID effects
• Share to Pharmaceutical studies and practices
• Share to Pharmacogenetics and Drug Metabolism